Literature DB >> 21781679

Antiemetic activity of antioxidants against cisplatin-induced emesis in dogs.

Y K Gupta1, S S Sharma.   

Abstract

Antioxidants such as glutathione, N-(2-mercaptopropionyl)glycine (MPG), vitamin E, vitamin C and a combination of vitamin E and vitamin C in different treatment schedules were evaluated for their antiemetic activity against cisplatin-induced emesis in dogs. While cisplatin-induced emesis was significantly reduced by all these agents, glutathione, MPG and combination of vitamin E and vitamin C produced maximum reduction. The antiemetic activity of antioxidants may be attributable to their ability to react with free radicals generated by cisplatin. The present study provides further evidence that free radicals play a role in cancer chemotherapy induced emesis and warrant clinical evaluation.

Entities:  

Year:  1996        PMID: 21781679     DOI: 10.1016/1382-6689(96)00008-7

Source DB:  PubMed          Journal:  Environ Toxicol Pharmacol        ISSN: 1382-6689            Impact factor:   4.860


  3 in total

1.  Synthetic and natural antioxidants attenuate cisplatin-induced vomiting.

Authors:  Javaid Alam; Fazal Subhan; Ihsan Ullah; Muhammad Shahid; Gowhar Ali; Robert D E Sewell
Journal:  BMC Pharmacol Toxicol       Date:  2017-01-13       Impact factor: 2.483

2.  Can acetylcysteine ameliorate cisplatin-induced toxicities and oxidative stress without decreasing antitumor efficacy? A randomized, double-blind, placebo-controlled trial involving patients with head and neck cancer.

Authors:  Marília B Visacri; Júlia C F Quintanilha; Vanessa M de Sousa; Laís S Amaral; Rosiane de F L Ambrósio; Luciane Calonga; Silvia F B B Curi; Mayra F de T Leme; Carlos T Chone; João M C Altemani; Priscila G Mazzola; Carina Malaguti; Aníbal E Vercesi; Carmen S P Lima; Patricia Moriel
Journal:  Cancer Med       Date:  2019-04-11       Impact factor: 4.452

3.  Antimetabolite TTL-315 selectively kills glucose-deprived cancer cells and enhances responses to cytotoxic chemotherapy in preclinical models of cancer.

Authors:  James DuHadaway; George C Prendergast
Journal:  Oncotarget       Date:  2016-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.